The Bioceramic MoonSwatch MISSION TO EARTHPHASE Celebrates the Splendor of The Earth as Seen from The Moon
NV
5 min read
66

The Bioceramic MoonSwatch MISSION TO EARTHPHASE Celebrates the Splendor of The Earth as Seen from The Moon

October 30, 2024
0

Reading Time: 3 minutes The Bioceramic MoonSwatch MISSION TO EARTHPHASE celebrates our two nearest celestial bodies, the Earth and the Moon. Swatch’s new non-limited creation not only comes with a moon phase, but more importantly-and for the first time in watchmaking history-an earth phase. Never before have these two

Continue Reading
CSP
22 min read
34

Notice Convening an Extraordinary General Meeting of Shareholders

October 30, 2024
0

Reading Time: 15 minutes THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IF YOU ARE IN ANY DOUBT AS TO THE ACTION YOU SHOULD TAKE, YOU SHOULD SEEK ADVICE FROM YOUR INDEPENDENT LEGAL, TAX, FINANCIAL OR PROFESSIONAL ADVISOR IMMEDIATELY.     VanEck US Fallen

Continue Reading
Xsolla to Launch Xsolla ZK, Advancing Web3 Adoption for Video Games
BWI
4 min read
37

Xsolla to Launch Xsolla ZK, Advancing Web3 Adoption for Video Games

October 30, 2024
0

Reading Time: 3 minutes Los Angeles, United States:   Xsolla, a global video game commerce company, announces plans to launch Xsolla ZK and introduce a digital backpack of virtual items on the blockchain. Xsolla ZK is powered by ZKsync technology and will drive the continuous growth

Continue Reading
Invitation to a webinar about Crunchfish’s interim report for Q3 2024
CSP
1 min read
21

Invitation to a webinar about Crunchfish’s interim report for Q3 2024

October 30, 2024
0

Reading Time: < 1 minute On Friday, November 1st at 08.30 CET / 13.00 IST, Crunchfish publishes its Q3 report for 2024. At 08.45 CET / 13.15 IST, a webinar about the report will be hosted on Zoom where Crunchfish CEO Joachim Samuelsson will be interviewed

Continue Reading
Rimini Street Announces Fiscal Third Quarter 2024 Financial and Operating Results
BWI
18 min read
42

Rimini Street Announces Fiscal Third Quarter 2024 Financial and Operating Results

October 30, 2024
0

Reading Time: 25 minutes Las Vegas, United States:   Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced results for the

Continue Reading
Swedavia’s quarterly report for July–September 2024: More passengers and higher commercial revenue contributed to increased net revenue, strengthened operating income and positive profit before tax
CSP
4 min read
14

Swedavia’s quarterly report for July–September 2024: More passengers and higher commercial revenue contributed to increased net revenue, strengthened operating income and positive profit before tax

October 30, 2024
0

Reading Time: 3 minutes A positive international travel trend, higher commercial revenues and fee adjustments strengthened Swedavia’s net revenue during the third quarter of the year, despite an uncertain global environment. Net revenue for the quarter increased to SEK 1,698 M (1,613). Cash flow from

Continue Reading
The Estée Lauder Companies Announces the Appointment of Stéphane de La Faverie as President and Chief Executive Officer
BWI
9 min read
40

The Estée Lauder Companies Announces the Appointment of Stéphane de La Faverie as President and Chief Executive Officer

October 30, 2024
0

Reading Time: 6 minutes New York, United States:   de La Faverie to Assume Role on January 1, 2025 William P. Lauder to Step Down as Executive Chairman, Will Remain Board Chair   The Estée Lauder Companies Inc. (NYSE: EL), a global leader in

Continue Reading
CSP
1 min read
19

BioStock: Robust data drives Alligator Bioscience forward

October 30, 2024
0

Reading Time: < 1 minute Alligator Bioscience has certainly had a successful 2024 according to its Q3 report. With promising phase II results from its leading drug candidate mitazalimab, strong partnerships, and a clear strategy for the future, the company is poised to make significant strides

Continue Reading
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
BWI
6 min read
38

US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)

October 30, 2024
0

Reading Time: 4 minutes Shanghai, China & JERSEY CITY, N.J., United States:   Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an investigational biosimilar of PROLIA/XGEVA (denosumab).

Continue Reading
CSP
2 min read
16

G5 Entertainment named one of Europe’s Long-Term Growth Champions 2025

October 30, 2024
0

Reading Time: < 1 minute G5 Entertainment has been named as one of Europe’s Long-Term Growth Champions according to the Financial Times special report in November this year. The report, published by the Financial Times in partnership with Statista, one of the world’s leading statistics

Continue Reading